Media Coverage

2/28/19
An article about the impact the partial government shutdown is having on broad segments of society interviews Anthony D. Martinez, MD, clinical associate professor of medicine and an addiction medicine specialist, who has been able to help about 95 patients by prescribing suboxone to help wean them off opioids. The article notes that the federal government mandates that doctors prescribe the drug to no more than 100 patients unless they apply for a waiver that allows them to treat up to 275 people, but with the Substance Abuse and Mental Health Administration shut down, waivers aren’t being processed.
2/19/19
New research suggests that lupus is linked to the overgrowth of certain bacteria in the intestines. “The results showed that lupus patients have gut microbiome patterns different from healthy individuals, and these changes correlated with disease activity,” said Jessy J. Alexander, PhD, research professor of medicine.
2/11/19
A perspective piece written by Andrew H. Talal, MD, professor of medicine in the Division of Gastroenterology, Hepatology and Nutrition, describes a study that reported that low testosterone persists in men even after hepatitis C virus is cleared. “The study highlights the important relationships between common viral infections and male hypogonadism,” he wrote.
2/9/19
New data from the Centers for Disease Control and Prevention have found this year’s flu vaccine is a good match for the virus strains in circulation “This year the circulating strains of influenza virus appear to be well-matched with the vaccine strains,” said John A. Seliick Jr., DO, professor of medicine in the Division of Infectious Diseases.
1/18/19
Anne B. Curtis, MD, SUNY Distinguished Professor and Charles and Mary Bauer Professor and chair of the Department of Medicine, discussed new technologies embedded in watches and other wearables shown at the annual Consumer Electronics Show. “I’ve made diagnoses on patients by looking at these [recordings] a few days later,” she said. “All you have to do is have the symptoms last long enough for a patient to turn on an app and make a 30-second recording.”
1/17/19
An article about EyeBOX, a noninvasive tool created to help in the diagnosis of concussion, quotes John J. Leddy, MD, clinical professor of orthopaedics and medical director of UB’s Concussion Management Clinic. “Looking beyond this milestone, EyeBox has the potential to aid in the diagnosis of other neurological conditions and may benefit researchers developing therapies for TBI and concussion,” he said.
12/17/18
Jeffrey M. Lackner, PsyD, professor of medicine, discussed recently published results of a landmark NIH clinical trial that evaluated cognitive behavioral therapy (CBT) as a method for relieving symptoms of irritable bowel syndrome, common misconceptions of CBT, and how a gastroenterologist can approach patients who are candidates for CBT.
12/12/18
An article about whether doctors are being unfairly criticized for their role in the opioid crisis interviews Nancy H. Nielsen, MD, PhD, senior associate dean for health policy. "Without access to legal prescriptions, they are forced to go to street dealers for their pills,” said Nielsen, also clinical professor of medicine. “As we reduced the number of opioids out there, chronic pain patients become medical refugees. People are dying.”
12/7/18
An article about why so many adults are reluctant to get a flu shot despite scientific evidence that shows the benefits of the vaccine interviews Thomas A. Russo, MD, professor of medicine and chief of infectious diseases. “Historically, adults do poorly with vaccines,” he said. “The other thing is that there is a fair amount of misinformation out there.” A related article about why people should get a flu shot every year features answers by local and national experts, including Russo. “Whenever you take any medication, there’s a small but finite chance you can have an adverse reaction to it,” he said, “but it’s very rare with the flu vaccine.”
11/27/18
A feature story on a website covering news in diabetes, covers the work of Paresh Dandona, MD, PhD, SUNY Distinguished Professor of medicine and chief of endocrinology, diabetes and metabolism, that has shown that drugs developed for Type 2 diabetes are also effective in treating patients with Type 1 diabetes. Dandona now is recruiting patients with Type 1 diabetes in a major Juvenile Diabetes Research Foundation-funded clinical trial to further test these drugs.
11/26/18
Nancy H. Nielsen, MD, PhD, senior associate dean for health policy, was quoted in an article about a plan by President Donald Trump that would gradually lower drug payment levels to levels based on international prices and set payment amounts for storing and handling drugs that are not tied to the drug’s cost. “This latest proposal is innovative, very good and long overdue. It’s a step in the right direction and it’s a smart model,” Nielsen said. “However, it’s going to face enormous opposition to come to fruition.”
11/26/18
An article about medical crowdfunding campaigns and the role that GoFundMe now plays in paying for health care interviews Nancy H. Nielsen, MD, PhD, senior associate dean for health policy. “The Affordable Care Act had three goals. Two of them got met,” she said, noting that one goal was to reform insurance abuses like denial of coverage to people with pre-existing conditions. Insuring as many people as possible was the second goal, she said, adding, “The third goal was to reduce costs. The third goal was not met.”
11/15/18
Anne B. Curtis, MD, Charles and Mary Bauer Professor and chair of medicine, was selected as a panelist on the American College of Cardiology Hour With Dr. Valentin Fuster that was released during the 2018 American Heart Association Scientific Sessions. Curtis joined Fuster and three other cardiologists to share their perspectives on the most significant science released during the conference.
11/5/18
Paresh Dandona, MD, PhD, SUNY Distinguished Professor of medicine and chief of endocrinology, diabetes and metabolism, was interviewed about his $1.6 million grant from the Juvenile Diabetes Research Foundation, in which he is enrolling Type 1 diabetes patients in a study of his “triple therapy” approach involving insulin plus two additional drugs that he has found help even out blood sugar control in Type 1 diabetics.
10/11/18
Peter Winkelstein, MD, executive director of the Institute for Healthcare Informatics and professor of pediatrics, and Timothy Murphy, MD, senior associate dean for clinical and translational research and SUNY Distinguished Professor of medicine, are interviewed about federally funded clinical trials conducted through UB. The number has seen a substantial uptick in the last three years, the result of a long-term effort to break down barriers within the university and a dedicated outreach effort in the community. “This substantial increase in research activity at UB is a result of all the changes this institution has made in a variety of areas to foster better health care in our community,” Murphy said. “Those efforts signaled UB’s strong institutional commitment to growing clinical research with a multimillion-dollar investment that allows us to fully support and perform world-class clinical research. Now they are paying off.”